Indaptus Therapeutics (INDP) Revenue & Revenue Breakdown
Indaptus Therapeutics Revenue Highlights
Indaptus Therapeutics Revenue by Period
Indaptus Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Indaptus Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Indaptus Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $1.93K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Indaptus Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Indaptus Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ASMB | Assembly Biosciences | $7.16M | $5.79M |
| NTRB | Nutriband | $2.09M | $442.83K |
| LGVN | Longeveron | $709.00K | $548.00K |
| ABVC | ABVC BioPharma | $152.43K | $117.14K |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| FBRX | Forte Biosciences | - | - |
| MTCR | Metacrine | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| RNXT | RenovoRx | - | - |
| TPST | Tempest Therapeutics | - | - |
| INDP | Indaptus Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| KPRX | Kiora Pharmaceuticals | - | $20.00K |
| BWV | Onconetix | - | - |
| KTTA | Pasithea Therapeutics | - | - |
INDP Revenue FAQ
What is Indaptus Therapeutics’s yearly revenue?
Indaptus Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. INDP's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Indaptus Therapeutics’s quarterly revenue?
Indaptus Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). INDP's quarterly revenue for Q4 2023 was $1.93K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Indaptus Therapeutics’s revenue growth rate?
Indaptus Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.